The clinical application of streptomycin, as for any other potent drug, requires reliable information on blood levels of the drug. Microbiological assays will give estimates subject to wide variations unless a sufficient number are performed to permit statistical evaluation.
No takes yet. Share an insight, caveat, or question.
Boxer et al. (1947) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: